Floatz logo

8,8'-(CARBONYLBIS(IMINO-3,1-PHENYLENECARBONYLIMINO(4-METHYL-3,1-PHENYLENE)CARBONYLIMINO))BIS-1,3,5-NAPHTHALENETRISULFONIC ACID

Adrenocortical Carcinoma

Mayo ClinicSmall moleculePhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

22 Active assets in the Adrenocortical Carcinoma cohort.

Asset / SponsorPhaseRating
CIS-DIAMMINEDICHLOROPLATINUM II
Vanderbilt-Ingram Cancer Center
Phase 2BB
Inno-206
National Cancer Institute (NCI)
Phase 2BB
Cyclophosphamide
Anusha Kalbasi
Phase 2B
Pembrolizumab
Corcept Therapeutics
Phase 2B
Nivolumab
Dana-Farber Cancer Institute
Phase 2B

View all 43 →

Same molecule, other indications

8,8'-(CARBONYLBIS(IMINO-3,1-PHENYLENECARBONYLIMINO(4-METHYL-3,1-PHENYLENE)CARBONYLIMINO))BIS-1,3,5-NAPHTHALENETRISULFONIC ACID is also rated in:

non-small cell lung carcinomaDormant
BB
Indicative ·
69 / 100
View asset →
central nervous system neoplasmDormant
B
Indicative ·
62 / 100
View asset →
prostate cancerDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →